Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review

Frontiers in Immunology(2020)10.3389/fimmu.2020.01036Source: DataRank Database

Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.53)OA: goldTopics (51)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Alejandro J. Garcia ORCID,Brice Chanez ORCID,Anne Madroszyk ORCID,Daniel Olive ORCID,Edward B. Garon ORCID

Live enrichment

PubMed:32670271 PMC:PMC7327092 OpenAlex:https://openalex.org/W3037818128

NCI NIH HHS

Grant: R01 CA208403

National Institutes of Health

Grant: 5R01CA208403-05

A model for predicting response to PD-1 inhibitors in NSCLC

Fondation de France

National Institutes of Health

Fondation pour la Recherche Médicale

FWCI

0.53

Citation Percentile

0.5%

Citation Trend

2020

2021

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.01036/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.01036/pdf

publisherhttps://www.frontiersin.org/article/10.3389/fimmu.2020.01036/full

journalhttps://doi.org/10.3389/fimmu.2020.01036

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32670271

Fields of Study

Cancer Immunotherapy and BiomarkersImmune cells in cancerImmunotherapy and Immune Responses0301 basic medicine03 medical and health sciences0302 clinical medicineAntineoplastic AgentsBiomarkers, TumorHumansImmune Checkpoint InhibitorsImmunotherapyLung NeoplasmsMolecular Targeted TherapyMonitoring, ImmunologicTreatment Outcome

MeSH Terms

Immune Checkpoint InhibitorsAntineoplastic AgentsHumansImmunotherapyLung NeoplasmsBiomarkers, TumorMonitoring, ImmunologicTreatment OutcomeMolecular Targeted Therapy

Keywords

Immune systemLung cancerMass cytometryMedicineImmune checkpointCancerImmunotherapyImmunologyBiomarkerCancer researchBiologyOncologyInternal medicineChemotherapyImmune monitoringImmune BiomarkerLung Neoplasms[SDV.IMM] Life Sciences [q-bio]/ImmunologyAntineoplastic AgentsRC581-607Treatment OutcomeMonitoring, ImmunologicBiomarkers, TumorHumansMolecular Targeted TherapyImmunologic diseases. AllergyImmune Checkpoint Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Medical Treatment of Lung Cancer: Can Immune Cells Predict the Response? A Systematic Review

FAIR Checklist

Authors (6)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)